Insight into the relationship between obesity-induced low-level chronic inflammation and COVID-19 infection

What we know and what we need to know about adenovirus 36-induced obesity

(2020) Jihye Kim et al.   INTERNATIONAL JOURNAL OF OBESITY

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

(2020) Chaolin Huang et al.   LANCET

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

(2020) Zhe Xu et al.   Lancet Respiratory Medicine

Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic

(2020) Livio Luzi et al.   ACTA DIABETOLOGICA

The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China

(2020) Wen Zhang et al.   CLINICAL IMMUNOLOGY

COVID-19 and the role of chronic inflammation in patients with obesity

(2020) Sonja Chiappetta et al.   INTERNATIONAL JOURNAL OF OBESITY

Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)

(2020) Li Runfeng et al.   PHARMACOLOGICAL RESEARCH

The effect of lipopolysaccharide-induced obesity and its chronic inflammation on influenza virus-related pathology

(2015) Sun-Young Ahn et al.   ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY